Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KokenTSE:7963 -0.16%66 EV-to-EBIT is 9.82 as of Sep. 06, 2026, which is 36% below its 10-year median of 15.29. GuruFocus rates TSE:7963 with a GF Score™ of 66/100 and a GF Value™ of 円1,496.43 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 475 Medical Devices & Instruments companies, Koken ranks better than 75.79% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Koken's Enterprise Value is 円11,462 Mil.
Koken's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was 円1,167 Mil. Therefore, Koken's EV-to-EBIT for today is 9.82.
The historical rank and industry rank for Koken's EV-to-EBIT or its related term are showing as below:
TSE:7963'
s EV-to-EBIT Range Over the Past 10 Years
Min: 8.22 Med: 15.29 Max: 44.03
Current: 9.82
During the past 13 years, the highest EV-to-EBIT of Koken was 44.03. The lowest was 8.22. And the median was 15.29.
TSE:7963's EV-to-EBIT is ranked better than 75.79% of 475
companies
in the Medical Devices & Instruments industry
Industry Median: 18.61
vs TSE:7963: 9.82
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Koken's Enterprise Value for the quarter that ended in Jun. 2026 was 円10,916 Mil.
Koken's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,167 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Koken EV-to-EBIT Related Terms
Koken EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Koken's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Koken's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koken EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koken's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Koken's EV-to-EBIT falls into.
Koken's current Enterprise Value is 円11,462 Mil.
Koken's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,167 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Koken (TSE:7963) has a EV-to-EBIT of 9.82 as of Sep. 06, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Koken and its competitors. This is 36% below median its historical median of 15.29. Over the past decade, Koken's EV-to-EBIT has ranged from 8.22 to 44.03. According to the industry distribution chart, Koken ranks #115 out of 475 companies in the Medical Devices & Instruments industry, placing it in the top 24.2%.
Is Koken's EV-to-EBIT too high?
Koken's current EV-to-EBIT of 9.82 is 36% below median its 10-year median of 15.29. Over the past 10 years, this metric has ranged from a low of 8.22 to a high of 44.03. The Medical Devices & Instruments industry median EV-to-EBIT is 18.61. Koken's value of 9.82 is 47.2% below this industry median. Based on the distribution chart, Koken ranks #115 out of 475 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Koken has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Koken's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koken ranks #115 out of 475 companies for EV-to-EBIT. This places Koken in the top 24% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 18.61. Koken's value of 9.82 is 47.2% below this benchmark. Historically, Koken's own EV-to-EBIT has ranged from 8.22 to 44.03 over the past decade. While the company's 10-year median is 15.29 vs. the industry median of 18.61, Koken has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.61, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koken's current EV-to-EBIT of 9.82 is 47.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Koken and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koken's current EV-to-EBIT is 9.82, which is 36% below median its own 10-year median of 15.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koken stock overvalued right now?
Based on GuruFocus' analysis, Koken (TSE:7963) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,496.43, compared to a current price of 円1,826.00 — trading 22% above its estimated fair value. The current EV-to-EBIT is 9.82, which is 36% below median its 10-year median of 15.29 and 47.2% below the Medical Devices & Instruments industry median of 18.61. Koken's overall GF Score™ is 66/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Koken (TSE:7963), the current EV-to-EBIT is 9.82 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koken (TSE:7963) Overvalued in 2026?
Based on GuruFocus' analysis, Koken stock appears to be overvalued.
The current stock price of 円1,826.00 is trading 22% above its estimated GF Value™ of 円1,496.43.
GuruFocus considers Koken to be Modestly Overvalued.
Key valuation signals for TSE:7963:
EV-to-EBIT: 9.82 (36% below median its 10-year median of 15.29)
GF Value™: 円1,496.43 vs. price of 円1,826.00 (22% above fair value)
Industry Position: 47.2% below the Medical Devices & Instruments median (#115 of 475)
No single metric tells the full story. See the TSE:7963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koken Ltd is engaged in the production and sales of occupational and health protective equipment, including particulate respirators, chemical cartridge respirators, and others. It is also involved in the production and sales of environmental quality improvement equipment.
66GF Score
Get the complete analysis for TSE:7963
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7963 has been successfully added to your 
